FDA Approves Ketamine-Like Drug for Severe Depression

WEDNESDAY, March 6, 2019 — The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine — a relative of the club drug and anesthetic ketamine — for use against severe depression. Sold as Spravato, the fast-acting drug becomes the first new type of medicine approved in…